UnitedHealth Group Inc. Under DOJ Investigation for Medicare Practices

UnitedHealth Group Inc., the largest health insurer in the United States, is currently facing scrutiny from the US Department of Justice (DOJ) over its Medicare practices. The company has confirmed that it is cooperating with both criminal and civil investigations initiated by the DOJ, as reported by multiple financial news sources on July 24, 2025.

The investigations have added to the challenges UnitedHealth has been facing since late 2024. Despite the company’s proactive approach in reaching out to the DOJ, its stock experienced a decline following the confirmation of these probes. On July 24, UnitedHealth’s stock fell by 2.43%, reflecting investor concerns over the potential implications of the investigation.

UnitedHealth Group, headquartered in Minnetonka, Minnesota, operates as a major player in the health care sector, specializing in organized health systems and employee benefit programs. With a market capitalization of approximately $261.32 billion and a close price of $292.51 on July 22, 2025, the company remains a significant entity in the health care industry.

The company has emphasized that it does not expect to be charged with any wrongdoing and is fully cooperating with the DOJ’s requests. This cooperation includes complying with formal criminal and civil requests, as stated in an SEC filing and reiterated by company representatives.

The investigation into UnitedHealth’s Medicare billing practices marks another hurdle for the company, which has been navigating various challenges over the past months. Despite these issues, UnitedHealth continues to serve customers globally, maintaining its position as a leading health care provider.

As the situation develops, stakeholders and investors will be closely monitoring the outcomes of the DOJ’s investigation and its potential impact on UnitedHealth’s operations and financial performance.